Literature DB >> 17460777

Necrosis induction in glioblastoma cells reveals a new "bioswitch" function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision.

Anissa Belkaid1, Simon Fortier, Jian Cao, Borhane Annabi.   

Abstract

Cytoskeleton disorganization is an early step in the activation process of matrix metalloproteinase 2 (MMP-2) by membrane type 1 MMP (MT1-MMP) but is also associated with endoplasmic reticulum (ER) dysfunction and subsequent cell death. Given evidence that the ER-embedded glucose-6-phosphate transporter (G6PT) regulates glioblastoma cell survival and that MT1-MMP is a key enzyme in the cancer cell invasive phenotype, we explored the molecular link between G6PT and MT1-MMP. Cytoskeleton-disrupting agents such as concanavalin A (ConA) and cytochalasin D triggered proMMP-2 activation and cell death in U87 glioma cells. ConA decreased G6PT gene expression, an event that was also observed in cells overexpressing the full-length recombinant MT1-MMP protein. Overexpression of a membrane-bound catalytically active but cytoplasmic domain-deleted MT1-MMP was unable to downregulate G6PT gene expression or to trigger necrosis. Gene silencing of MT1-MMP with small interfering RNA prevented proMMP-2 activation and induced G6PT gene expression. ConA inhibited Akt phosphorylation, whereas overexpression of recombinant G6PT rescued the cells from ConA-induced proMMP-2 activation and increased Akt phosphorylation. Altogether, new functions of MT1-MMP in cell death signaling may be linked to those of G6PT. Our study indicates a molecular signaling axis regulating the invasive phenotype of brain tumor cells and highlights a new "bioswitch" function for G6PT in cell survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460777      PMCID: PMC1854846          DOI: 10.1593/neo.07142

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  55 in total

Review 1.  "...those left behind." Biology and oncology of invasive glioma cells.

Authors:  M E Berens; A Giese
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL.

Authors:  Jennifer S Carew; Steffan T Nawrocki; Yelena V Krupnik; Kenneth Dunner; David J McConkey; Michael J Keating; Peng Huang
Journal:  Blood       Date:  2005-09-06       Impact factor: 22.113

3.  Palmitoylation at Cys574 is essential for MT1-MMP to promote cell migration.

Authors:  Narayanapanicker Anilkumar; Takamasa Uekita; John R Couchman; Hideaki Nagase; Motoharu Seiki; Yoshifumi Itoh
Journal:  FASEB J       Date:  2005-06-09       Impact factor: 5.191

Review 4.  Mediators of endoplasmic reticulum stress-induced apoptosis.

Authors:  Eva Szegezdi; Susan E Logue; Adrienne M Gorman; Afshin Samali
Journal:  EMBO Rep       Date:  2006-09       Impact factor: 8.807

5.  MT1-MMP down-regulates the glucose 6-phosphate transporter expression in marrow stromal cells: a molecular link between pro-MMP-2 activation, chemotaxis, and cell survival.

Authors:  Jean-Christophe Currie; Simon Fortier; Asmaa Sina; Jacques Galipeau; Jian Cao; Borhane Annabi
Journal:  J Biol Chem       Date:  2007-01-17       Impact factor: 5.157

Review 6.  Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy.

Authors:  S V McLennan; E Fisher; S Y Martell; A K Death; P F Williams; J G Lyons; D K Yue
Journal:  Kidney Int Suppl       Date:  2000-09       Impact factor: 10.545

Review 7.  Matrix metalloproteinases and their biological function in human gliomas.

Authors:  S K Chintala; J C Tonn; J S Rao
Journal:  Int J Dev Neurosci       Date:  1999 Aug-Oct       Impact factor: 2.457

8.  The transmembrane domain is essential for the microtubular trafficking of membrane type-1 matrix metalloproteinase (MT1-MMP).

Authors:  Albert G Remacle; Dmitri V Rozanov; Peter C Baciu; Alexei V Chekanov; Vladislav S Golubkov; Alex Y Strongin
Journal:  J Cell Sci       Date:  2005-10-11       Impact factor: 5.285

9.  The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas.

Authors:  Arnab Chakravarti; Gary Zhai; Yoshiyuki Suzuki; Sormeh Sarkesh; Peter M Black; Alona Muzikansky; Jay S Loeffler
Journal:  J Clin Oncol       Date:  2004-05-15       Impact factor: 44.544

Review 10.  ER stress, hypoxia tolerance and tumor progression.

Authors:  Constantinos Koumenis
Journal:  Curr Mol Med       Date:  2006-02       Impact factor: 2.222

View more
  18 in total

Review 1.  Imaging hypoxia in gliomas.

Authors:  I Mendichovszky; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  MT1-MMP expression level status dictates the in vitro action of lupeol on inflammatory biomarkers MMP-9 and COX-2 in medulloblastoma cells.

Authors:  Borhane Annabi; Eric Vaillancourt-Jean; Richard Béliveau
Journal:  Inflammopharmacology       Date:  2012-06-16       Impact factor: 4.473

3.  Evidence for transcriptional regulation of the glucose-6-phosphate transporter by HIF-1alpha: Targeting G6PT with mumbaistatin analogs in hypoxic mesenchymal stromal cells.

Authors:  Simon Lord-Dufour; Ian B Copland; Louis-Charles Levros; Martin Post; Abhirup Das; Chaitan Khosla; Jacques Galipeau; Eric Rassart; Borhane Annabi
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

4.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

5.  The lectin concanavalin-A signals MT1-MMP catalytic independent induction of COX-2 through an IKKgamma/NF-kappaB-dependent pathway.

Authors:  Asmaa Sina; Sébastien Proulx-Bonneau; Alain Roy; Laurent Poliquin; Jian Cao; Borhane Annabi
Journal:  J Cell Commun Signal       Date:  2010-01-27       Impact factor: 5.782

6.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

Review 7.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.

Authors:  Randy L Jensen
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

Review 8.  Molecular Functions of Glycoconjugates in Autophagy.

Authors:  Kamau Fahie; Natasha E Zachara
Journal:  J Mol Biol       Date:  2016-06-23       Impact factor: 5.469

9.  Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion.

Authors:  D S Markovic; K Vinnakota; S Chirasani; M Synowitz; H Raguet; K Stock; M Sliwa; S Lehmann; R Kälin; N van Rooijen; K Holmbeck; F L Heppner; J Kiwit; V Matyash; S Lehnardt; B Kaminska; R Glass; H Kettenmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-15       Impact factor: 11.205

10.  Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo.

Authors:  Tatiana V Kolesnikova; Alexander R Kazarov; Madeleine E Lemieux; Marc A Lafleur; Santosh Kesari; Andrew L Kung; Martin E Hemler
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.